AI Tools for Private Equity Associates
AI tools that help private equity associates build LBO models, analyze SEC filings, screen acquisition targets, and prepare investment committee memos.
Works in Chat, Cowork and Code
Target company financial analysis from SEC filings
Pull SEC filings to extract the financial metrics needed for your LBO model and IC memo. Get 5 years of revenue, EBITDA, cash flow, capex, and working capital data without manually downloading 200-page PDFs.
Clarivate 3-year analysis. Revenue CAGR 2022–2024: +8.4% (organic +3.1%). EBITDA margin: 34.2%→35.8%→37.1% (expanding). Unlevered FCF conversion: 54% (below typical software — drag from intangible amortization). Net debt/EBITDA: 6.2x (elevated post-Proquest acquisition). Debt maturities: $1.4B term loan due 2026, $1.6B senior notes due 2028. Key risk: 2026 maturity wall requires refinancing at current higher rates.
LBO returns modeling and bid range calculation
Calculate entry-to-exit IRR and MOIC under multiple scenarios. Model different debt structures, exit multiples, and hold periods to stress-test returns and determine the maximum price you can pay to hit your fund's return hurdle.
Entry equity: $180M (30% equity check). Year 5 EBITDA (12% CAGR): $141M. Exit EV at 8.5x: $1.2B. Net debt year 5 (after FCF sweep): $285M. Exit equity: $915M. MOIC: 5.1x. IRR: 38.7% (base case). Bear case (8x exit, 8% CAGR): MOIC 2.9x, IRR 23.8%. Both exceed the 20% hurdle. Maximum EV to achieve 20% IRR at base case assumptions: $760M (9.5x EBITDA).
Deal sourcing and target identification
Find mid-market acquisition targets by searching for companies in specific sectors with management changes, recent capital raises, or divestitures signaling a potential sale process. Build a curated target list for outreach.
Found 18 companies matching criteria. Top 5: Waystar Health — $95M ARR, CFO departed (signal), hospital billing focus. Verisma Systems — founder-led, $42M ARR, raised $28M Series C in 2020. Accuity Delivery Systems — revenue cycle, no recent funding (organic growth, ripe for buyout). Omega Healthcare — BPO with SaaS layer, $60M ARR. RevPoint Analytics — founder age 58 (succession risk), $38M ARR. All have identifiable CEOs for direct outreach.
Pre-bid regulatory and litigation screening
Before submitting an IC memo or final bid, screen the target company and management team for SEC enforcement history, DOJ investigations, and material litigation. Surface legal risks that are not disclosed in the CIM.
SolarWinds: SEC filed civil fraud charges in Oct 2023 against the company and CISO Timothy Brown for misleading investors about cybersecurity practices. SolarWinds settled the SEC charges for $26M penalty (2024). Brown's charges largely dismissed on appeal. Class action settled for $26M in 2022. No ongoing DOJ criminal proceedings. Key due diligence flag: check remaining D&O insurance coverage and any indemnification obligations to Brown that survive closing.
Sector deal comp and public comp research
Research recent M&A transactions to establish deal multiple benchmarks. Build the comps table section of your IC memo with current public multiples and precedent transaction data from comparable deals.
PE vertical SaaS buyouts 2023–2024 (28 transactions): EV/NTM Revenue average 5.8x (range 3.5x–9.2x). Healthcare SaaS trades at 15–25% premium: Cotiviti (PE-to-PE, $4.9B EV, 4.8x revenue), Availity (Vista Equity, ~6.5x revenue). General vertical SaaS: Veradigm (7.1x), Solera (5.4x). Public comps: VEEV 11.2x, NOW 14.4x, WDAY 7.1x NTM revenue. Healthcare SaaS EV/EBITDA: 18–22x for profitable names.
Ready-to-use prompts
Pull the last 3 annual 10-K filings and the most recent 10-Q for [company ticker]. Extract: annual revenue with growth rates, EBITDA with margins, free cash flow, capex as % of revenue, working capital change, total debt outstanding with maturity dates, and any auditor changes or restatements. Format as a table for LBO model inputs.
Model an LBO at $450M EV (7.2x EBITDA of $62.5M). Debt: $270M senior TLB at SOFR+350bp, $45M second lien at 11%. 5-year hold, EBITDA growing 10% per year. Build a sensitivity table: exit multiples 6.5x, 7.5x, 8.5x on the X axis and EBITDA CAGR 6%, 10%, 14% on the Y axis. Show IRR and MOIC for each cell. What is the breakeven exit multiple for 20% IRR?
Research precedent M&A transactions in healthcare IT and revenue cycle management software from 2022–2024. Find deals above $100M. Show: buyer, seller, deal value, EV/Revenue, EV/EBITDA, and whether the deal was PE buyout or strategic acquisition. I need this for the IC memo valuation section.
Find B2B software companies in the supply chain management space with $15–50M EBITDA that are founder-led or have had a CEO change in the last 18 months. Also include companies that raised Series C or D funding 4–7 years ago. I am building a direct outreach target list for our new platform vertical.
Search for SEC enforcement actions, DOJ investigations, state regulatory actions, and material class action lawsuits involving [target company name] and its named CEO, CFO, and General Counsel over the last 10 years. Flag any open matters, consent orders, or deferred prosecution agreements.
Pull current market data for these enterprise software companies: Salesforce (CRM), ServiceNow (NOW), Workday (WDAY), Veeva (VEEV), ANSYS (ANSS), and PTC. Show: market cap, enterprise value, EV/NTM Revenue multiple, EV/NTM EBITDA, NTM revenue growth rate, and gross margin. Format as a comps table.
Research current leveraged loan market conditions for new LBO financings: all-in TLB rates for B/B+ credits, current OID levels, recent CCC covenant-lite vs. cov-full new issue split, and any sectors where bank lenders are currently unwilling to provide financing at normal leverage multiples.
Research typical management equity incentive structures in PE-backed software buyouts above $300M EV: standard option pool size as % of equity, typical strike price relative to entry value, standard vesting schedules (time-based vs. performance), and IRR hurdles that trigger accelerated vesting. I am designing the rollover package for a new portfolio company CEO.
Tools to power your best work
165+ tools.
One conversation.
Everything private equity associates need from AI, connected to the assistant you already use. No extra apps, no switching tabs.
First-round bid preparation
Before submitting a first-round indication of interest, complete the financial analysis, regulatory screen, and sector research to build your preliminary valuation range.
Investment committee memo preparation
Build the full IC memo package: financial model, scenario analysis, deal comp research, and the risk section.
Deal sourcing outreach campaign
Build a targeted outreach list of acquisition candidates and intermediaries in your target sector.
Frequently Asked Questions
What financial metrics are most important when screening an LBO target?
Four key criteria: (1) EBITDA margin stability — LBOs require predictable cash generation to service debt; (2) Free cash flow conversion — target at least 60% of EBITDA converting to FCF; (3) Revenue predictability — recurring and subscription revenue is most highly valued; (4) Capex intensity — asset-light businesses support higher leverage. The ideal LBO candidate has 35%+ EBITDA margins, 70%+ FCF conversion, 60%+ recurring revenue, and capex below 5% of revenue.
How do I determine the maximum price I can pay for a target?
Work backwards from your return hurdle (typically 20% IRR or 2.5x MOIC for a 5-year hold). Build the LBO model at base case assumptions, then solve for the entry EV where IRR = 20%. That is your maximum bid. Sanity-check against recent sector comps — if your max bid is more than 1–2x turns above comparable transactions, you need a specific premium justification such as superior growth, proprietary deal, or synergies with an existing portfolio company.
What regulatory due diligence should I do before submitting a final bid?
At minimum: (1) Screen the company and all C-suite executives for SEC enforcement actions and FINRA disciplinary history using the Regulatory Actions tool; (2) Search for DOJ investigations and civil class action lawsuits in news databases; (3) Check for FCPA (Foreign Corrupt Practices Act) issues if the company has international operations; (4) Review the most recent 10-K risk factors section for government investigation disclosures; (5) Check state regulatory licenses for any disciplinary actions (particularly for healthcare, financial services, or environmental businesses).
What is the difference between a sponsor-to-sponsor secondary and a platform acquisition?
A sponsor-to-sponsor secondary is buying a company from another PE firm — typically after the seller has owned it 4–7 years and completed initial value creation. Entry multiples are usually higher. A platform acquisition is buying the first company in a new sector where you intend to add bolt-on acquisitions — entry multiples may be lower but complexity grows with each add-on. Platform strategies require more intensive operations work but can generate higher returns through multiple expansion and scale.
How does the leveraged loan market affect deal pricing?
When credit markets are tight — spreads wide, OID high, lenders unwilling to finance certain sectors — PE sponsors must either use more equity (reducing returns) or accept less leverage (modeling lower IRRs). In 2022–2023, TLB spreads widened 100–150bp and OID moved from 98 to 95–96 cents, adding 2–3% to effective borrowing costs and compressing IRRs by 3–5 percentage points for deals with identical EBITDA growth and exit multiple assumptions. Research current market conditions using the Deep Research tool before finalizing your debt structure assumptions.
Give your AI superpowers.
Works in Chat, Cowork and Code